EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients.

[1]  S. Loukides,et al.  New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis , 2023, Clinical science.

[2]  D. Strachan,et al.  Asthma management and control in children, adolescents, and adults in 25 countries: a Global Asthma Network Phase I cross-sectional study , 2023, The Lancet. Global health.

[3]  A. Muraro,et al.  Allergen immunotherapy for allergic asthma - The future seems bright. , 2023, Respiratory medicine.

[4]  A. Leunig,et al.  The EUFOREA pocket guide for chronic rhinosinusitis. , 2022, Rhinology.

[5]  G. Koppelman,et al.  Biologic Therapies for Severe Asthma. , 2022, The New England journal of medicine.

[6]  I. Pavord,et al.  Choosing a Biologic For Patients With Severe Asthma , 2021, The Journal of Allergy and Clinical Immunology: In Practice.

[7]  R. Pawankar,et al.  Allergic Rhinitis in Childhood and the New EUFOREA Algorithm , 2021, Frontiers in Allergy.

[8]  B. Lipworth,et al.  Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline , 2021, American journal of respiratory and critical care medicine.

[9]  D. Ryan,et al.  EUFOREA treatment algorithm for allergic rhinitis , 2020, Rhinology journal.

[10]  A. Waljee,et al.  Burst Case Scenario: Why Shorter May Not Be Any Better When It Comes to Corticosteroids , 2020, Annals of Internal Medicine.

[11]  R. Gerth van Wijk,et al.  Toward clinically applicable biomarkers for asthma: An EAACI position paper , 2019, Allergy.

[12]  D. Ryan,et al.  ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions , 2019, European Respiratory Journal.

[13]  S. Loukides,et al.  Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits. , 2018, Respiratory medicine.

[14]  A. Sheikh,et al.  EAACI guidelines on allergen immunotherapy: Executive statement , 2018, Allergy.

[15]  D. Postma,et al.  Higher patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: a cross-sectional analysis. , 2006, Respiratory medicine.

[16]  I. Pavord,et al.  Tackling ‘People Remodelling’ in Corticosteroid-dependent Asthma with Type-2 Targeting Biologics and a Formal Corticosteroid Weaning Protocol , 2022, US Respiratory & Pulmonary Diseases.

[17]  N. Hanania,et al.  Precision medicine and treatable traits in chronic airway diseases - where do we stand? , 2019, Current opinion in pulmonary medicine.